MEETINGS - Exploring trends in biotechnology: a strategy workshop for investors & executives (US) April 2001:
This article was originally published in Clinica
Global Prior Art, a consulting firm based in Boston, Massachusetts, will hold a meeting entitled Exploring trends in biotechnology: a strategy workshop for investors & executives at the Meridien Hotel, Boston, on April 17. The workshop will focus on complete patent maps of single nucleotide polymorphisms (SNP); microarray; and pulmonary drug delivery sectors. For more information contact Peter Kolchinsky. Tel: +1 617 320 8789. Email: firstname.lastname@example.org www.globalpriorart.com
You may also be interested in...
Medical products that do not fully comply with Canadian requirements but are manufactured according to comparable standards are being allowed into the country to deal with COVID-19-related shortages.
A randomized COVID-19 study spanning the whole of the UK could help to bolster the UK’s reputation as a location for future clinical trials. It is also being seen partly as the result of the UK regulator's "decisive action" in fast-tracking trials for potential COVID-19 therapies.
Manufacturers of endoscopic equipment, biofeedback devices and thermometers were among those cited for regulatory violations in US FDA warning letters this week. A total of four device-related enforcement missives were released by the agency.